US 8263091
Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
granted A61KA61K2039/55561A61K31/7115
Quick answer
US patent 8263091 (Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/55561, A61K31/7115, A61K31/7125, A61K39/39